Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Viruses|October 14, 2011
Development of ST-246® for Treatment of Poxvirus InfectionsRobert Jordan, Janet M Leeds, Shanthakumar Tyavanagimatt, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justificationRobert Jordan, Arthur Goff, Annie Frimm, et al.
Expert Review of Clinical Pharmacology|August 18, 2023
Emerging pharmacological strategies for treating and preventing mpoxDouglas W Grosenbach, Andrew T Russo, Emily D Blum, et al.
Protein Expression and Purification|March 16, 2005
Development of PLEX, a plasmid-based expression system for production of heterologous gene products by the gram-positive bacteria Streptococcus gordoniiTravis K Warren, S Amanda Lund, Kevin F Jones, et al.
Canadian Journal of Microbiology|June 1, 2007
Comparison of transformation protocols in Streptococcus gordonii and evaluation of native promoter strength using a multiple-copy plasmidTravis K Warren, S Amanda Lund, Kevin F Jones, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2012
A novel inhibitor of dengue virus replication that targets the capsid proteinChelsea M Byrd, Dongcheng Dai, Douglas W Grosenbach, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicaseChelsea M Byrd, Douglas W Grosenbach, Aklile Berhanu, et al.
Journal of Bacteriology|September 25, 2002
Escherichia coli DegP protease cleaves between paired hydrophobic residues in a natural substrate: the PapA pilinC Hal Jones, Paul Dexter, Amy K Evans, et al.
Virology Journal|March 3, 2006
Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteinsJennifer D Yoder, Tsefang S Chen, Cliff R Gagnier, et al.
Pageof 9